Health policy: Me-too drugs with limited benefits-the tale of regorafenib for HCC

Bishal Gyawali, Vinay Prasad

Research output: Contribution to journalShort surveypeer-review

19 Scopus citations
Original languageEnglish (US)
Pages (from-to)653-654
Number of pages2
JournalNature Reviews Clinical Oncology
Issue number11
StatePublished - Nov 1 2017

ASJC Scopus subject areas

  • Oncology

Cite this